-
Tel
- Tel+65 89686988
-
E-mail
- E-mailmarketing@cytoniche.com
- TOP
Events & News
Aug 27,2025
CytoNiche at Cell & Gene Therapy World Asia 2025
September 10–11, 2025 | Sheraton Towers Singapore
Aug 12,2025
Closing the CMC Gap: How Next-Gen Manufacturing Unlocks the True Promise of MSCs
Following the landmark FDA approval of Mesoblast’s cell therapy, CytoNiche’s 3D platform resolves scalability and cost barriers have long hindered the industry.
Jul 23,2025
Singapore | July 21, 2025 — CytoNiche Biotech celebrated the grand opening of its 3D FloTrix™ Experience Hub in Singapore, marking a pivotal step in globalizing its breakthrough 3D cell manufacturing platform—the technology behind China’s first approved stem cell drug, priced at just 1/70th the cost of comparable therapies (e.g., $194,000/dose in the U.S. vs. ~$2,700/dose in China).
Leading a new era of cell industrialization
3D FloTrix™ Experience Hub
TEE International Limited, Level 6, 25 Bukit Batok Street 22, Singapore 659591
CytoNiche, FloTrix, TableTrix, RecomTrix, Architect for Cells and the microcarrier icon are trademarks of CytoNiche Biotech.
Copyright © 2025 CytoNiche Biotech Pte Ltd.